Sage Therapeutics, Inc (SAGE) Forward P/E Multiple

Official company branding of Sage Therapeutics Inc. (SAGE)

Sage Therapeutics, Inc. (SAGE) leads in the therapy of CNS disorders, having developed the unique drug Zurzuvae. The GURU.Markets terminal provides a chart of the company's expected P/E ratio, where 0.00 becomes the new value of the indicator. Growth potential is supported by robotic molecule discovery and streamlined raw material logistics, which minimize operational disruptions during the development of new neuropreparations.

SAGE - Sage Therapeutics Inc. Projected Price to Earnings Ratio over the range 07/04/2022 - 08/16/2025

Comprehensive metric breakdowns and analytics for Sage Therapeutics, Inc. (SAGE)

Fundamental valuation:sagerx.com
Product sample of Sage Therapeutics Inc

The forward P/E reflects the market value of the business relative to its projected annual earnings, allowing for an assessment of the premium paid for future cash flows. By analyzing the forward price-to-earnings ratio of Sage Therapeutics, Inc. (SAGE), an investor can identify a fundamental valuation trend, which for Sage Therapeutics, Inc. (SAGE) is supported by strong pricing power and the uniqueness of precision medications for the treatment of severe postpartum depression amid inelastic demand.

Competitors of Sage Therapeutics, Inc. (SAGE)

Forward P/E Multiple BIIB|NBIX - Projected Price to Earnings Ratio|Forward P/E Multiple RGC (Regencell Bioscience Ltd)|Market Cap to Projected Earnings axsome.com (AXSM)|ACADIA Pharmaceuticals Inc - Forward P/E Multiple|Projected Price to Earnings Ratio Xenon Pharmaceuticals Inc.|Viking Therapeutics (VKTX) - Future Price to Earnings|Supernus Corp - Future Price to Earnings Multiple|Projected Price to Earnings CPRX|Denali Therapeutics Inc. (DNLI) - Market Cap to Projected Earnings|Projected Price to Earnings HRMY (Harmony Corp)|BHVN - Projected Price to Earnings Ratio|Future Price to Earnings Amylyx Pharmaceuticals, Inc. AMLX|Future Price to Earnings Multiple TRVI|PRAX - Future Price to Earnings|Market Cap to Projected Earnings Anavex Life Sciences AVXL|CBLL: Forward P/E Multiple|Projected Price to Earnings Prothena Corporation PLC|ALEC (alector.com) - Forward P/E Multiple|Projected Price to Earnings Annexon, Inc. (ANNX)|Future Price to Earnings Omeros Corporation (OMER)|Neurogene Inc. - Price to Future Earnings Ratio|acimmune.com - Projected Price to Earnings|Forward P/E Multiple Voyager Therapeutics Inc VYGR|NMRA - Future Price to Earnings|Forward Price to Earnings Multiple Scilex Holding Company (SCLX)|Tevogen Bio Holdings (TVGN) - Future Price to Earnings|Price to Future Earnings Ratio ACOG|Future Price to Earnings Cognition Therapeutics, Inc.|Inhibikase Therapeutics, Inc. - Price to Expected Earnings Ratio|Projected Price to Earnings SAVA (Cassava)|Market Cap to Projected Earnings Assertio Therapeutics|Coya Therapeutics, Inc. - Projected Price to Earnings|Market Cap to Future Earnings Ratio VTGN (VistaGen Therapeutics Inc)|Ovid Therapeutics Inc - Forward P/E Multiple|Acumen Pharmaceuticals, Inc. (ABOS) - Projected Price to Earnings|CRVO (CervoMed, Inc.) - Projected Price to Earnings|Projected Price to Earnings Alterity Therapeutics Ltd|Future Price to Earnings Clene Inc.|PepGen Inc. - Price to Expected Earnings Ratio|Projected Price to Earnings JUNS (Jupiter Neurosciences Inc)|Future Price to Earnings RLMD (Relmada Therapeutics Inc)|Annovis Bio Inc - Projected Price to Earnings|Market Cap to Projected Earnings Grace Tx (GRCE)|fireflyneuro.com - Forward P/E Multiple|Klotho Neurosciences (KLTO) - Projected Price to Earnings|NeuroSense Therapeutics, Ltd. (NRSN) - Future Price to Earnings|Price to Expected Earnings Ratio RVPH (Reviva Pharmaceuticals Holdings, Inc.)|MTVA (MetaVia) - Forward P/E Multiple|NRXS: Future Price to Earnings Multiple|Forward P/E Multiple HSDT|Forward P/E Multiple Passage Bio Inc. (PASG)|Future Price to Earnings bionomics.com.au NEUP|Forward P/E Multiple Minerva Neurosciences Inc NERV|ATHA: Projected Price to Earnings|ADXN (Addex Therapeutics, Ltd.) - Price to Future Earnings Ratio|Alzamend Neuro Inc. (ALZN) - Future Price to Earnings|Cyclerion - Future Price to Earnings Multiple|Future Price to Earnings protagenic.com|Pasithea Therapeutics - Price to Expected Earnings Ratio|Projected Price to Earnings CRGT (Cortigent, Inc.)|Avenue Therapeutics - Price to Future Earnings Ratio|Future Price to Earnings Brainstorm Cell BCLI|Forward P/E Multiple caratherapeutics.com CARA|Chromocell Therapeutics Corp. - Forward P/E Multiple|eliemtx.com - Market Cap to Future Earnings Ratio|Intra-Cellular Therapies (ITCI) - Future Price to Earnings|LBPH (Longboard) - Future Price to Earnings|MRNS (marinuspharma.com) - Forward P/E Multiple|Projected Price to Earnings Ratio NKGen Biotech NKGN|Future Price to Earnings NeuroBo Pharma (NRBO)|Market Cap to Projected Earnings Neurotrope|Future Price to Earnings Trevena, Inc. TRVN|Vigil Neuroscience (VIGL) - Projected Price to Earnings Ratio|WENA: Projected Price to Earnings|Future Price to Earnings Multiple CERE (Cerevel Therapeutics)